Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.

Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F, Chadwick DR, Clark R, Cosgrove C, Galloway J, Goodman AL, Heer A, Higham A, Iyengar S, Jamal A, Jeanes C, Kalra PA, Kyriakidou C, McAuley DF, Meyrick A, Minassian AM, Minton J, Moore P, Munsoor I, Nicholls H, Osanlou O, Packham J, Pretswell CH, San Francisco Ramos A, Saralaya D, Sheridan RP, Smith R, Soiza RL, Swift PA, Thomson EC, Turner J, Viljoen ME, Albert G, Cho I, Dubovsky F, Glenn G, Rivers J, Robertson A, Smith K, Toback S, 2019nCoV-302 Study Group

Open source

DOI
10.1056/nejmoa2107659
Published
2021 Sep 23
Container
The New England journal of medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2107659,
  title = {Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.},
  author = {Heath PT and Galiza EP and Baxter DN and Boffito M and Browne D and Burns F and Chadwick DR and Clark R and Cosgrove C and Galloway J and Goodman AL and Heer A and Higham A and Iyengar S and Jamal A and Jeanes C and Kalra PA and Kyriakidou C and McAuley DF and Meyrick A and Minassian AM and Minton J and Moore P and Munsoor I and Nicholls H and Osanlou O and Packham J and Pretswell CH and San Francisco Ramos A and Saralaya D and Sheridan RP and Smith R and Soiza RL and Swift PA and Thomson EC and Turner J and Viljoen ME and Albert G and Cho I and Dubovsky F and Glenn G and Rivers J and Robertson A and Smith K and Toback S and 2019nCoV-302 Study Group},
  year = {2021},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2107659},
  url = {https://doi.org/10.1056/nejmoa2107659}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
AU  - Heath PT
AU  - Galiza EP
AU  - Baxter DN
AU  - Boffito M
AU  - Browne D
AU  - Burns F
AU  - Chadwick DR
AU  - Clark R
AU  - Cosgrove C
AU  - Galloway J
AU  - Goodman AL
AU  - Heer A
AU  - Higham A
AU  - Iyengar S
AU  - Jamal A
AU  - Jeanes C
AU  - Kalra PA
AU  - Kyriakidou C
AU  - McAuley DF
AU  - Meyrick A
AU  - Minassian AM
AU  - Minton J
AU  - Moore P
AU  - Munsoor I
AU  - Nicholls H
AU  - Osanlou O
AU  - Packham J
AU  - Pretswell CH
AU  - San Francisco Ramos A
AU  - Saralaya D
AU  - Sheridan RP
AU  - Smith R
AU  - Soiza RL
AU  - Swift PA
AU  - Thomson EC
AU  - Turner J
AU  - Viljoen ME
AU  - Albert G
AU  - Cho I
AU  - Dubovsky F
AU  - Glenn G
AU  - Rivers J
AU  - Robertson A
AU  - Smith K
AU  - Toback S
AU  - 2019nCoV-302 Study Group
PY  - 2021
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2107659
UR  - https://doi.org/10.1056/nejmoa2107659
ER  - 

APA

PT, H., EP, G., DN, B., M, B., D, B., F, B., DR, C., R, C., C, C., J, G., AL, G., A, H., A, H., S, I., A, J., C, J., PA, K., C, K., DF, M., A, M., AM, M., J, M., P, M., I, M., H, N., O, O., J, P., CH, P., A, S. F. R., D, S., RP, S., R, S., RL, S., PA, S., EC, T., J, T., ME, V., G, A., I, C., F, D., G, G., J, R., A, R., K, S., S, T., & Group, 2. S. (2021). Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2107659

Source records